End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 MYR | -0.95% | 0.00% | -16.13% |
Feb. 20 | Nova Wellness Group Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
2023 | Nova Wellness' Profit, Revenue Drop in Fiscal Q1 | MT |
Valuation
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 203.4 | 271.7 | 279.7 | 219.9 | 165.7 | - | - |
Enterprise Value (EV) 1 | 203.4 | 271.7 | 259.3 | 219.9 | 165.7 | 165.7 | 165.7 |
P/E ratio | 15.6 x | 18.7 x | 17.6 x | 14.6 x | 11.4 x | 10.1 x | 8.25 x |
Yield | - | - | 2.33% | 3.04% | 5.06% | 5.51% | 7.88% |
Capitalization / Revenue | - | 6.71 x | 5.69 x | 4.83 x | 3.62 x | 3.29 x | 2.92 x |
EV / Revenue | - | 6.71 x | 5.69 x | 4.83 x | 3.62 x | 3.29 x | 2.92 x |
EV / EBITDA | - | 13.3 x | 12.3 x | 10.9 x | 7.92 x | 7.03 x | 6.05 x |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | 2.85 x | 2.75 x | 2.09 x | 1.44 x | 1.33 x | - |
Nbr of stocks (in thousands) | 317,744 | 317,744 | 317,794 | 318,720 | 318,720 | - | - |
Reference price 2 | 0.6400 | 0.8550 | 0.8800 | 0.6900 | 0.5200 | 0.5200 | 0.5200 |
Announcement Date | 8/18/20 | 9/9/21 | 8/25/22 | 8/18/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 40.48 | 49.14 | 45.53 | 45.8 | 50.4 | 56.8 |
EBITDA 1 | - | 20.4 | 22.69 | 20.17 | 20.93 | 23.57 | 27.4 |
EBIT 1 | - | 19.29 | - | 17.84 | 16.6 | 18 | - |
Operating Margin | - | 47.65% | - | 39.18% | 36.24% | 35.71% | - |
Earnings before Tax (EBT) 1 | - | 19.29 | 20.1 | 19.76 | 18.97 | 21.47 | 26.2 |
Net income 1 | 13 | 14.56 | 15.92 | 14.99 | 14.57 | 16.47 | 20 |
Net margin | - | 35.96% | 32.41% | 32.93% | 31.8% | 32.67% | 35.21% |
EPS 2 | 0.0409 | 0.0458 | 0.0501 | 0.0472 | 0.0457 | 0.0517 | 0.0630 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | 0.0205 | 0.0210 | 0.0263 | 0.0287 | 0.0410 |
Announcement Date | 8/18/20 | 9/9/21 | 8/25/22 | 8/18/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | 20.4 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | 16.1% | 16.4% | 14.5% | 14% | 14.5% | 18.5% |
ROA (Net income/ Total Assets) | - | 14.5% | 14.7% | 13.1% | 10.2% | 9.9% | - |
Assets 1 | - | 100.4 | 108.4 | 114.6 | 142.8 | 166.3 | - |
Book Value Per Share 2 | - | 0.3000 | 0.3200 | 0.3300 | 0.3600 | 0.3900 | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 5.45 | - | 9.32 | 8.8 | 6.4 | - |
Capex / Sales | - | 13.47% | - | 20.47% | 19.21% | 12.7% | - |
Announcement Date | 8/18/20 | 9/9/21 | 8/25/22 | 8/18/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.13% | 34.76M | |
+8.20% | 7.78B | |
+1.64% | 7.38B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-12.75% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-40.56% | 879M | |
-17.65% | 836M |
- Stock Market
- Equities
- NOVA Stock
- Financials Nova Wellness Group